LOADING
Comparing Coca-Cola Company (KO) and Thermo Fisher Scientific (TMO) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | KO | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $368.5B | $242.1B |
| P/E Ratio | 25.7 | 35.2 |
| Forward P/E | 25.3 | 24.1 |
| PEG Ratio | 4.03 | 1.98 |
| EPS | $3.33 | $18.60 |
| Revenue Growth (YoY) | 6.7% | 10.5% |
| Profit Margin | 28.6% | 15.0% |
| Return on Equity | 42.0% | 13.5% |
| Dividend Yield | 2.42% | 0.28% |
| Beta | 0.34 | 0.85 |
| 52-Week High | $91.94 | $683.63 |
| 52-Week Low | $64.14 | $434.50 |
| Volume | -- | -- |
Coca-Cola Company is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Coca-Cola Company offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.